| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EMR | Common Stock | Award | +18,488 | +7% | 283,904 | 04 Nov 2024 | Direct | F1, F2 | ||
| transaction | EMR | Common Stock | Tax liability | $890,665 | -8,163 | -2.9% | $109.11 | 275,741 | 04 Nov 2024 | Direct | F3, F4 |
| transaction | EMR | Common Stock | Award | +8,192 | +3% | 283,933 | 04 Nov 2024 | Direct | F5, F6 | ||
| holding | EMR | Common Stock | 845 | 04 Nov 2024 | Profit Sharing Plan | ||||||
| holding | EMR | Common Stock | 11,505 | 04 Nov 2024 | 401(k) plan | ||||||
| holding | EMR | Common Stock | 1,350 | 04 Nov 2024 | 401(k) excess plan |
| Id | Content |
|---|---|
| F1 | Acquisition of shares pursuant to Rule 16b-3 upon payout of 18,488 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2024. |
| F2 | Price is not applicable to the acquisition described in Note 1. |
| F3 | Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1. |
| F4 | Fair market value on date of withholding described in Note 1. |
| F5 | Grant to Reporting Person of 8,192 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
| F6 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |